| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

HB Fuller Upgraded To Buy At Seaport Global, Shares Rise 1%

Seaport Global Securities upgraded HB Fuller (NYSE: FUL) from Neutral to Buy with a price target of $80.00, sending shares up more than 1% pre-market on Friday.

The firm said HB Fuller was positioned to deliver strong year-on-year EBITDA growth in fiscal 2025 despite sluggish demand, citing margin expansion supported by lower costs and mix improvements. Analysts noted that EBITDA margin rose 110 basis points year-over-year even as volumes declined, reflecting effective execution in pricing, procurement, portfolio restructuring, and manufacturing optimization.

Engineering Adhesives led growth with a 14% EBITDA increase, while Building Adhesive Solutions also outperformed underlying markets, aided by demand from data center construction and growth in the Middle East. The Hygiene, Health & Consumables segment was weaker but saw partial offset from medical applications.

Seaport projected additional $25 million in price/cost tailwinds in FY26 and roughly $70 million in optimization benefits through FY30. At 7.8x forward EBITDA, below the 3-year average of 9.0x, analysts said the valuation supported the upgrade.


 

Published on: September 26, 2025